These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 7176819)

  • 1. Scopolamine self-administration: cholinergic involvement in reward mechanisms.
    Glick SD; Guido RA
    Life Sci; 1982 Aug; 31(9):909-13. PubMed ID: 7176819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central muscarinic receptors and male rat sexual behavior: facilitation by oxotremorine but not arecoline or pilocarpine in methscopolamine pretreated animals.
    Ahlenius S; Larsson K
    Psychopharmacology (Berl); 1985; 87(2):127-9. PubMed ID: 3931135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats.
    See RE; Chapman MA
    Pharmacol Biochem Behav; 1991 May; 39(1):49-54. PubMed ID: 1924511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic effects on spatial exploration and its memory.
    Kelly PH; Malanowski J
    Can J Physiol Pharmacol; 1993; 71(5-6):352-64. PubMed ID: 8402401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of muscarinic receptor agonists and antagonists on alpha 2-adrenoceptors in rat brain.
    Hollingsworth PJ; Smith CB
    Eur J Pharmacol; 1989 Sep; 168(2):159-67. PubMed ID: 2558024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of yawning behavior induced by apomorphine, physostigmine and pilocarpine.
    Ushijima I; Mizuki Y; Imaizumi J; Yamada M; Noda Y; Yamada K; Furukawa T
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):196-201. PubMed ID: 4004417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus properties of physostigmine in rats.
    Tang AH; Franklin SR
    Eur J Pharmacol; 1988 Aug; 153(1):97-104. PubMed ID: 3215280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic drug effects on a delayed conditional discrimination task in the rat.
    Herremans AH; Hijzen TH; Olivier B; Slangen JL
    Behav Neurosci; 1995 Jun; 109(3):426-35. PubMed ID: 7662153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-muscarinic drug effects in a swim-to-platform test: dose-response relations.
    Vanderwolf CH
    Behav Brain Res; 1991 Aug; 44(2):217-9. PubMed ID: 1751013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cholinergic agonists on the dorsal immobility response.
    Potter TJ; Cottrell GA; Van Hartesveldt C
    Pharmacol Biochem Behav; 1990 May; 36(1):77-80. PubMed ID: 2349272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus properties of muscarinic agonists.
    Jung M; Costa L; Shearman GT; Kelly PH
    Psychopharmacology (Berl); 1987; 93(2):139-45. PubMed ID: 3122245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential response to cholinergic stimulation in psychogenitically selected rat lines.
    Martin JR; Driscoll P; Gentsch C
    Psychopharmacology (Berl); 1984; 83(3):262-7. PubMed ID: 6433388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic modulation of spatial learning in mice in a Morris-type water maze.
    Lamberty Y; Gower AJ
    Arch Int Pharmacodyn Ther; 1991; 309():5-19. PubMed ID: 1888229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze.
    Magnani M; Pozzi O; Biagetti R; Banfi S; Dorigotti L
    Psychopharmacology (Berl); 1992; 106(2):175-8. PubMed ID: 1549645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cholinergic drugs on prey-killing by rodents.
    Wnek DJ; Leaf RC
    Physiol Behav; 1973 Jun; 10(6):1107-13. PubMed ID: 4736903
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonmuscarinic neurotoxicity of oxotremorine.
    Witkin JM; Alvarado-Garcia R; Lee MA; Witkin KM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):34-41. PubMed ID: 3572794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic-induced emotional defecation: effects of scopolamine and haloperidol.
    Sanberg PR; Russell KH; Hagenmeyer-Houser SH; Giordano M; Zubrycki EM; Garver DL
    Psychopharmacology (Berl); 1989; 99(1):60-3. PubMed ID: 2506605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic mechanisms and sexual behavior in the male rabbit.
    Agmo A
    Psychopharmacology (Berl); 1976 Dec; 51(1):43-5. PubMed ID: 827774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the aversive qualities of shock through a central inhibitory cholinergic system in the rat.
    Houser VP
    Pharmacol Biochem Behav; 1976 May; 4(5):561-8. PubMed ID: 951435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.